|
|
Volumn 22, Issue 1, 2011, Pages 76-77
|
|
Evidence for use of fibrates in diabetic dyslipidemia: Are we looking hard enough?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APOLIPOPROTEIN A1;
FENOFIBRATE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
SIMVASTATIN;
TRIACYLGLYCEROL;
VERY LOW DENSITY LIPOPROTEIN;
ATHEROGENESIS;
CARDIOVASCULAR RISK;
CLINICAL DECISION MAKING;
COMBINATION CHEMOTHERAPY;
COST EFFECTIVENESS ANALYSIS;
DIABETES MELLITUS;
DIABETIC PATIENT;
DRUG EFFICACY;
DYSLIPIDEMIA;
EDITORIAL;
EVIDENCE BASED PRACTICE;
HEART INFARCTION;
HEART PROTECTION;
HUMAN;
LIPID METABOLISM;
LIPOPROTEIN METABOLISM;
META ANALYSIS (TOPIC);
METABOLIC SYNDROME X;
MONOTHERAPY;
PRIORITY JOURNAL;
STROKE;
TREATMENT RESPONSE;
DIABETES COMPLICATIONS;
DYSLIPIDEMIAS;
FIBRIC ACIDS;
HUMANS;
PPAR ALPHA;
|
|
EID: 78751616267
PISSN: 09579672
EISSN: None
Source Type: Journal
DOI: 10.1097/MOL.0b013e328342b0e9 Document Type: Editorial |
|
Times cited : (2)
|
|
References (0)
|
